Economics of EK procedures: 'Could be better, but ain't that bad'

With the influx of numerous endothelial keratoplasty procedures, only 15% of corneal transplants last year were PK, said Donald T.H. Tan, MD. » Click for alternative PK suggestions

"Vision Associates was just the spark my dispensary needed."

"Vision Associates custom built and installed a turnkey program that helped steer me in the right direction and dramatically increased our profits." Dr. John Meyer- Partner, The EyeCare Institute, Louisville, KY. ASCRS Booth #2311
More

Why you should consider phakic IOLs for correcting myopia

Phakic IOL implantation is as potentially viable a means to correct myopia as LASIK/PRK or refractive lens exchange, said Sonia H. Yoo, MD. » Find out why

Fibrin glue 'viable option' when capsular support lacks

Fixating a posterior chamber IOL using fibrin glue is a good option in patients with deficient capsular support, said Mahipal S. Sachdev, MBBS, MD. » Find out why

Bean-shaped rings offer capsular support where none exists

Bean-shaped rings can be useful devices for implantation of bag-in-the-lens in eyes with loose or no capsular support, said Marie José B. Tassignon, MD, PhD. » Read why

FROM THE SHOW FLOOR

• InnFocus reaches 75-patient treatment milestone

• BVI device made for intraop small pupil management

Abbott @AbbottNews

Want to learn where the future of vision health is headed? #ASCRSASOA2015 Here's what we think: http://bit.ly/1OTmnQ8

Malosa Medical @MalosaMedical

We are LOVING the @GaslampQuarter #ASCRSASOA2015

Wills Eye Hospital @Wills_Eye

Former Wills cornea chief Elizabeth Cohen MD recommends use of herpes zoster vaccine at #ASCRSASOA2015

ASCRS @ASCRStweets

President Robert J. Cionni closes his address with the importance of advocacy and unity #ASCRSASOA2015

Top Tweets

We welcome your feedback!
Please send your comments to:

Mark L. Dlugoss

Group Content Director

UBM Advanstar Eyecare Group

[email protected]

DISCLAIMER:
This information has been independently developed and provided by the editors of Ophthalmology Times.
The sponsors do not endorse and are not responsible for the accuracy of the content or for practices or standards of non-sponsor sources. These articles may discuss regimens that have not been approved by the FDA.
For full prescribing information including indications, contraindications, warnings, precautions, and adverse experiences, please see the appropriate manufacturer's product circular.

Editorial Questions? Contact the Editorial Team Click Here. Sales, Reprints, Classified questions? Contact the Sales Team Click Here.

TOP STORIES